title: Urinary tract infections of Escherichia coli strains of chaperone-usher system.
abstract: Urinary tract infections are a very serious health and economic problem affecting millions of people each year worldwide. The most common etiologic agent of this type of bacterial infections, involving the upper and lower urinary tract, are E. coli strains representing approximately 80% of cases. Uropathogenic E. coli strains produce several urovirulence factors which can be divided into two main types, surface virulence factors and exported virulence factors. Surface-exposed structures include mainly extracellular adhesive organelles such as fimbriae/pili necessary in adhesion, invasion, biofilm formation and cytokine induction. Among the surface-exposed polymeric adhesive structures there are three most invasive groups, type 1 pili, type P pili and Dr family of adhesins which are bioassembled via the conserved, among Gram-negative bacteria, chaperone-usher secretion system. Type 1 and P-piliated E. coli cause cystitis and pyelonephritis. The Dr family of adhesins recognizing DAF receptor is responsible for cystitis, pyelonephritis (especially in pregnant women) and diarrhoea (in infants). In addition, Dr-positive E. coli strains carry the risk of recurrent urinary tract infections. Pyelonephritis in pregnant women leads to a series of complications such as bacteremia, urosepsis, acute respiratory distress syndrome and even death. In the era of increasing drug resistance of bacteria, the development of vaccines, drugs termed pilicides and inhibitors of adhesion may be a promising tool in the fight against urogenital infections.
authors.affiliation: Department of Microbiology, Gdańsk University of Technology, Gdańsk, Poland. beazalew@pg.gda.pl
authors.forename: Beata M
authors.initials: BM
authors.lastname: Zalewska-Piatek
mesh_terms: D004927:Escherichia coli Infections / Q000382:microbiology* / Q000628:therapy; D010861:Fimbriae, Bacterial; D006801:Humans; D014552:Urinary Tract Infections / Q000382:microbiology* / Q000628:therapy; D056689:Uropathogenic Escherichia coli / Q000472:pathogenicity*; D037521:Virulence Factors
chemical_list: D037521:Virulence Factors